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Dendritic cells (DC) are critical for stimulation of naive T cells. Little is known about the effect of herpes
simplex virus type 2 (HSV-2) infection on DC structure or function or if the observed effects of HSV-1 on
human DC are reproduced in murine DC. Here, we demonstrate that by 12 h postinfection, wild-type (wt)
HSV-2 (186) abortively infected murine bone marrow-derived DC and induced early cell death compared to
UV-inactivated HSV-2 or mock-infected DC. HSV-2-induced loss of DC viability was more rapid than that
induced by HSV-1 and was due, in part, to apoptosis, as shown by TEM, caspase-3 activation, and terminal
deoxynucleotidyl transferase-mediated dCTP biotin nick end labeling. HSV induced type-specific changes in
the murine DC immunophenotype. At 12 h postinfection, wt HSV-2 upregulated DC major histocompatibility
complex (MHC) class II expression, and in contrast to UV-inactivated HSV-2, downregulated expression of
MHC class I, but it had no effect on surface CD40, CD80, or CD86. Wt HSV-1 (MC-1) induced only CD40
upregulation. More-profound effects on the DC immunophenotype were observed in HSV-2-infected neonatal
DC. Wt HSV of either serotype impaired murine DC-induced T-cell alloproliferation and lipopolysaccharide-
induced DC interleukin-12 secretion. Thus, there are marked differences in the levels of HSV-induced cytolysis
in DC according to the HSV serotype, although HSV-2 displays immunomodulatory effects on the DC immu-
nophenotype and function similar to those of HSV-1.
Dendritic cells (DC) play a key role in the induction of the
primary cellular immune response to intracellular pathogens
like herpes simplex virus (HSV), as they are the main cell type
that stimulates naive T cells in the draining lymph nodes (23).
The strength and character of the antigen-specific T-cell re-
sponse are determined by factors such as the level of costimu-
latory molecule (B-7) expression and the density of antigen
expressed on the surfaces of DC (1, 33). DC are also thought
to be the major source of interleukin-12 (IL-12) (31), which
has been demonstrated to play a pivotal role in the differen-
tiation of naive CD4 T cells into type 1 T helper (Th1) cells
(18), although recent studies suggest that IL-12 produced by
DC is required for optimal T-cell gamma interferon produc-
tion rather than for CD4-T-cell polarization (26).
HSV type 1 (HSV-1) infection of adult human DC derived
from peripheral blood monocytes (MoDC) has been shown by
a number of groups (15, 19, 27) to impair costimulatory mol-
ecule upregulation of immature DC. However, the timing and
degree of this impairment and the presence or absence of
associated effects on major histocompatibility complex (MHC)
class I (MHC-I) and MHC-II molecule expression were differ-
ent, possibly due to differences in the types of HSV-1 strain
used. Infection of immature MoDC with a disabled infectious
single-cycle mutant (DISC-HSV-1-GFP) inhibited DC matu-
ration (as shown by downregulation of costimulatory mole-
cules) and induced marked downregulation of MHC-I expres-
sion, attributed to ICP47 inhibition of the transporter
associated with antigen presentation (TAP) (27). HSV-1 infec-
tion of mature MoDC with either the disabled single-cycle
mutant or a laboratory-adapted HSV-1 strain (Ang) was also
nonproductive and induced downregulation of CD83 and
many defects in DC function, including reductions in DC-
induced T-cell alloproliferation, DC maturation and migra-
tion, and DC cytokine secretion (15, 27). In contrast, infection
of immature MoDC with a clinical HSV-1 isolate was produc-
tive of small amounts of infectious virus and induced asynchro-
nous downregulation of costimulatory molecules with no effect
on either MHC-I or MHC-II expression (19).
HSV infection of murine DC has not been well character-
ized. DC have been shown to be a major source of cytokine
secretion in HSV-infected murine skin (30) and to constitute
an effective vaccination strategy when primed with HSV
epitopes against HSV challenge in murine models (28). Simi-
larly, little is known about HSV-2 infection in any DC system.
Therefore, the aim of our study was to test the effect of HSV-2
infection on murine bone marrow-derived DC (BMDC) in
vitro compared to that of HSV-1 and to compare results with
MoDC from humans to those observed in BMDC from mice.
Our ultimate goal was to test whether murine DC would serve
as a suitable in vivo model of human DC function with which
to compare neonatal and adult murine DC function in later
studies of the immunopathogenesis of neonatal HSV disease.
(This work was presented in part at the 27th International
Herpesvirus Workshop, July 2002.)
* Corresponding author. Mailing address: Herpesvirus Research
Unit, The Children’s Hospital at Westmead, Locked Bag 4001, West-
mead NSW 2145, Australia. Phone: 61 2 9845 0521. Fax: 61 2 9845
3082. E-mail: cherylj@chw.edu.au.
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Mice. Five- to 6-week old BALB/c (H-2d) and C57BL/6 (H-2b) mice were
purchased from the Animal Resource Centre (Perth, Australia) and acclimatized
for at least 1 week before use. Bone marrow was harvested from female adult
mice at 6 to 12 weeks of age and from neonatal mice at 1 week of age. All
experiments were conducted with the approval of The Children’s Hospital at
Westmead and Westmead Hospital Animal Ethics committees.
Generation of murine BMDC. DC were generated from the long bones of
BALB/c mice by culture in sterile bacterial petri dishes in the presence of
granuloctye-macrophage colony-stimulating factor (GM-CSF) (20 ng/ml) (BD
PharMingen, San Diego, Calif.) as described elsewhere (17). Nonadherent cells
were collected on day 10 and positively selected for surface CD11c expression
using MidiMACS with LS separation columns (BD Biosciences, San Jose, Calif.)
to give a 97% pure population of CD11c MHCII cells, which were defined
as BMDC. The few remaining contaminants were mostly granulocytes and not B
cells, T cells, or macrophages, as shown by the absence of staining for B220,
F4/80, CD3, and CD4 on fluorescence-activated cell sorter (FACS) analysis (not
shown) after incubation with the relevant specific monoclonal antibodies (MAb)
outlined below. The generated population predominantly consisted of immature
BMDC (MHCIIlo CD11c) and 20 to 30% mature BMDC (MHCIIhi CD11c).
Virus preparation. Stocks of the wild-type (wt) HSV-2 strain 186syn-1 (29)
and the wt clinical HSV-1 strain MC-1 (19) were propagated and assayed as
described elsewhere (4). UV-inactivated 186 syn-1 virus (UV-HSV-2) and
UV-inactivated HSV-1 (UV-HSV-1) were prepared as previously reported so
that the postirradiation titer was 100 PFU/ml (4). All stocks were kept at
80°C and thawed immediately before use.
HSV infection of BMDC. Unless stated otherwise, 5  105 BMDC were
infected with wt HSV-2, wt HSV-1, UV-186 (preirradiation titer), or UV-HSV-1
(preirradiation titer) at multiplicities of infection (MOI) from 0.1 to 10 or mock
infected and incubated for 1 h at 37°C and 5% CO2. Infected BMDC were
washed three times with phosphate-buffered saline (PBS) to remove any cell
surface-bound virus and resuspended at 2  105/ml in RPMI 1640 (Invitrogen,
Groningen, The Netherlands) supplemented with a penicillin-streptomycin mix-
ture (Invitrogen), -mercaptoethanol (Sigma Aldrich, Castle Hill, Australia),
10% heat-inactivated fetal calf serum (FCS), 2 mM glutamine, and 20 ng of
GM-CSF (BD PharMingen)/ml and then cultured in a bacterial culture dish at
37°C and 5% CO2 for 12 h in GM-CSF-supplemented medium unless otherwise
indicated. The cells were then assessed for viability by the trypan blue exclusion
method, and viable DC were used to set up experiments as indicated.
Detection of HSV-infected BMDC. BMDC were infected with wt HSV-2,
UV-HSV-2, wt HSV-1, or UV-HSV-1 at an MOI of 4 and, together with unin-
fected controls, were incubated for 12 h and then washed as described above.
Cytospin preparations were mounted on slides with 105 cells/slide. The cells were
fixed in acetone for 5 min, blocked with 20% donkey serum (Jackson Immuno-
Research Laboratories, West Grove, Pa.) for 30 min at room temperature,
permeabilized with PBS– 0.1% Triton X-100, and then stained with a polycolonal
antibody against HSV-2 (1:1,000; Cortex Biochemical, San Leandro, Calif.),
followed by donkey anti-sheep immunoglobulin G-fluorescein isothiocyanate
(FITC) (1:1,000; Jackson ImmunoResearch), for HSV-2 strains or MAb against
HSV-1 gC directly conjugated to FITC for HSV-1 strains. DC were counter-
stained with 4,6-diamidino-2-phenylindole (DAPI) (Molecular Probes, Eugene,
Oreg.) and mounted on diazabicyclo(2.2.2.)octane (Sigma Aldrich). The slides
were examined using an Olympus BX50 immunofluorescence microscope. Five
photographs were taken of each slide with the fluorescence microscope, and the
percentage of infected DC was calculated by two independent observers.
To analyze the pattern of HSV gene expression after infection of BMDC with
wt HSV-2, DC were infected at an MOI of 4 and collected at 0, 2, 4, 6, 8, 12, 14,
16, and 18 h postinfection (p.i.). Cytospin slides were prepared and fixed as
described above, blocked with 20% goat serum (Jackson ImmunoResearch), and
then stained with antibodies against HSV ICP4 (M612446; BioClone), ICP8
(383; a kind gift from David Knipe, Harvard Medical School, Boston, Mass.), or
HSV-2 glycoprotein D (gD) (910; Biodesign International, Saco, Maine), fol-
lowed by FITC-conjugated goat anti-mouse MAb (Jackson ImmunoResearch).
Washes and mounting were performed as described above.
To determine if infection of BMDC with wt HSV-2 or wt HSV-1 was produc-
tive of infectious progeny, DC were infected for 1 h as described above at an
MOI of 0.4 or 4 or left untreated. Viable cells were plated in triplicate for each
serotype and dose (4  105 DC/2 ml of RPMI medium supplemented with
GM-CSF) in 24-well plates. The supernatant was collected at 0, 3, 6, 9, 12, 14, 16,
18, and 22 or 24 h p.i. and stored at 80°C until it was assayed. The titer of
infectious virus was determined by standard plaque assay as described elsewhere
(4).
Detection of apoptosis. To determine if HSV infection of BMDC induced
apoptosis, three methods were used: caspase-3 activation, analysis of ultrastruc-
tural morphology by transmission electron microscopy (TEM), and terminal
deoxynucleotide transferase-mediated (TdT) dCTP biotin nick end labeling
(TUNEL). Unless otherwise stated, BMDC were infected as described above at
an MOI of 4 with wt HSV-2 (strain 186), wt HSV-1 (MC-1), UV-HSV-2, or
UV-HSV-1 or left untreated and incubated at 37°C and 5% CO2 for the appro-
priate times.
For caspase-3 activation, 106 DC were infected with each HSV strain (wt
HSV-2, UV-HSV-2, wt HSV-1, and UV-HSV-1) and, together with uninfected
DC controls, were pelleted in triplicate; the supernatant was removed, and the
pellets were stored at 80°C until the time of assay. The level of caspase-3
activity in each DC pellet was determined by a colorimetric assay for caspase-3
in a 96-well plate (R&D Systems, Minneapolis, Minn.). In brief, the cell pellets
were lysed and mixed with reaction buffer, dithiothreonal, and colorimetric
substrate and then incubated for 1 h in accordance with the manufacturer’s
instructions. The levels of caspase-3 activity in infected DC cell lysates were then
determined spectrophotometrically by comparing the optical density reading at a
wavelength of 405 nm using a microplate reader (Bio-Tek Bio-Kinetics) with the
activities of uninfected DC controls and background controls (no cell lysate).
For TEM, infected or uninfected DC pellets (106 cells for each strain and
uninfected controls) were washed twice in RPMI medium containing no FCS,
fixed in modified Karnovsky’s fixative for 1 h at room temperature, and then
prepared as described elsewhere (20). In brief, the cells were washed twice with
0.1 M morpholinopropanesulfonic acid (MOPS) buffer; postfixed in 2% buffered
osmium tetroxide and then in 2% uranyl acetate, both for 1 h; dehydrated
through graded ethanols; and embedded in Spurr epoxy resin. The blocks were
polymerized for 10 h at 70°C. Ultrathin sections (70 nm) were collected from
each DC pellet onto 400-mesh thin-bar copper grids, stained (2% uranyl acetate
in 50% ethanol, followed by Reynold’s lead citrate), and then examined by TEM
using a Philips CM120 BioTWIN operated at 80 kV. As a positive control for
apoptosis, uninfected BMDC were irradiated with UV light (30-W bulb at 20 cm
for 2 min), incubated for 3 h in RPMI medium containing no FCS, washed twice,
and then fixed and processed for TEM as described above. For semiquantitative
analysis of the number of apoptotic cells, semithin sections (0.5 m) were cut
from the same DC pellets using an ultramicrotome (Leica Ultracut UCT), stained
with toluidine blue, and then counted by light microscopy (100 cells in two high-
power fields per slide, two slides per DC pellet, by two independent observers).
For the TUNEL assay, BMDC were infected at an MOI of 4 with wt HSV-2
or left untreated and collected at time points up to 12 h p.i. Cytospin slides were
prepared with 104 cells/slide, fixed in 4% paraformaldehyde, permeabilized with
PBS–0.1% Triton X-100 for 15 min at room temperature, washed in PBS, and
then labeled with biotin-14-dCTP to detect DNA breaks by nick translation.
Briefly, slides were treated with the labeling mix containing TdT reaction buffer
(0.5 M potassium cacodylate, pH 7, 10 mM CoCl2, 1 mM dithiothreitol), 50 M
biotin-14-CTP, and 0.2 U of TdT/l (all from Invitrogen) and then placed in a
humidified chamber at 37°C for 30 min, together with positive controls (mock-
infected slides pretreated with 50 l of 3-U/50 l of DNase I in 0.1 M sodium
acetate–5 mM MgCl2) and negative controls (no TdT in labeling mix). Texas
Red-avidin D (Vector Laboratories, Burlingame, Calif.) diluted 1:1,000 in PBS
was used to colorimetrically detect biotin-dCTP end-labeled (apoptotic) cells. To
test if the apoptotic cells were HSV-2 infected, the slides were blocked with 20%
donkey serum (Jackson ImmunoResearch) for 30 min at room temperature and
then stained with an antibody either against HSV ICP8 (383; David Knipe,
Harvard Medical School) or against HSV-2 gD (910; Biodesign International),
followed by FITC-conjugated goat anti-mouse MAb (Jackson ImmunoResearch
Laboratories) and then washed and mounted on DABCO (Sigma Aldrich) and
examined using Spot Advance software on an Olympus BX50 immunofluores-
cence microscope. The percentages of apoptotic cells (intense red nuclear stain-
ing), HSV-infected cells (intense green nuclear or cytoplasmic staining), and
double-labeled, apoptotic HSV-infected cells (yellow-stained nucleus or green
cytoplasm with red nucleus) were determined in 100 cells from 15 randomly
chosen microscopic fields per sample.
Flow cytometry. The immunophenotype of infected CD11c DC or uninfected
controls was analyzed 12 h p.i. by fluorescent labeling of cell surface markers
followed by FACs analysis (FACScan and Cell Quest software; BD BioSciences).
The monoclonal antibodies against CD11c (clone HL-3), CD40 (clone HM-40-
3), CD80 (clone 16-10A1), CD86 (clone GLI), and MHC class I H-2Kd (clone
SF1-1.1) were all directly conjugated with FITC, and anti-MHC class II I-Ad
(G155-178) was directly conjugated with phycoerythrin. The corresponding di-
rectly conjugated isotype MAb were used as negative controls; all were obtained
from BD PharMingen. Dead cells were excluded by costaining them with pro-
pidium iodide (PI).
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The purity of T-cell populations for alloproliferation assays were determined
by labeling them with MAb against CD3 (A19-3) and then FITC-conjugated goat
anti-hamster MAb (G70-204) or with MAb against CD45R (RA3-6B2) or
CD11b (M1/70) and then polycloncal FITC-conjugated goat anti-rat MAb (all
from BD PharMingen).
Measurement of T-cell proliferation. T-cell responders were prepared from
the spleens of C57BL/6 mice. Single-cell splenocyte suspensions were incubated
with hypotonic lysis buffer (0.15 M NH4Cl,1 g of NaHCO3/liter, 0.1 mM EDTA);
depleted of B cells and macrophages using CD45R (B220) and CD11b (MAC-1)
microbeads, respectively; and then passaged through MidiMACs separation col-
umns to give a population of 90 to 95% CD3 cells by FACS analysis. T cells were
resuspended at 3  106/ml in RPMI 1640.
DC were infected at an MOI of 4 using wt HSV-2, wt HSV-1, or UV-HSV-2
or mock-infected with PBS; incubated for 12 h at 37°C in RMPI as described
above; irradiated (3,000 rads); and washed, and the viable-cell count was deter-
mined by trypan blue exclusion. DC were added to responder T cells (105 T
cells/well) at ratios of 0.01:1 up to 1:1 in triplicate (final volume, 100 l) and then
incubated for 3 days at 37°C and 5% CO2. The cells were then labeled with 1 Ci
of [3H]thymidine (ICN) and harvested onto filter mats. The mats were dried and
sealed in bags with scintillant, and samples were counted with a Wallac micro-
beta counter (Perkin-Elmer). Phorbol myristate acetate (10 ng/ml) (Sigma Al-
drich)– ionomycin (500 ng/ml) stimulation of T-cell cultures was used as a
positive control, and DC incubated with syngeneic BALB/c T cells were used as
negative controls.
IL-12 secretion by DC. DC were infected with wt HSV-1 or HSV-2 or with
UV-HSV-2, all at an MOI of 4, or left untreated. Immediately p.i., the DC were
resuspended at 107/ml, and 106 cells/well were added to 96-well tissue culture
plates in triplicate for each sample or control. The cells were either left untreated
or stimulated with lipopolysaccharide (LPS) (50 ng/ml; Sigma Aldrich) or anti-
CD40 (0.01 g/ml; BD PharMingen) in a final volume of 300 l. After incubation
for 12, 18, or 24 h at 37°C and 5% CO2, the DC were pelleted and the super-
natant was collected and stored at 80°C until it was used. Levels of IL-12 were
assayed by standard enzyme-linked immunosorbent assay (OptEIA kit; BD
PharMingen) on immunopure Maxisorp microtiter plates (Nunc, Roskilde, Den-
mark), using 100 l of cell supernatant in triplicate per sample.
Statistical analysis. The differences in the observed values of loss of DC
viability and DC-induced T-cell alloproliferation were determined by the non-
parametric Wilcoxon rank sum test. The differences in the mean values of
caspase-3 induction and DC IL-12 cytokine production compared to controls
were determined by two-tailed Student’s t test. A P value of 0.05 was consid-
ered a significant difference.
RESULTS
A population of BMDC remains refractory to infection with
wt HSV even when exposed to large infectious doses of HSV.
The percentage of immature human MoDC infected with
HSV-1 has been shown to be proportional to the level of input
virus until a threshold of 80% is reached at a dose of 5 PFU/
cell (19). Increasing the amount of input HSV-1 beyond this
level did not increase the percentage of infected DC, suggest-
ing that a subpopulation was refractory to infection. To test the
susceptibility of immature murine DC to HSV-2 or HSV-1
infection, BMDC from adult mice were infected with wt
HSV-2 (strain 186), wt HSV-1 (MC-1), UV-HSV-2, or UV-
HSV-1 at various doses, and the percentage of HSV antigen-
positive cells was determined 12 h p.i. by immunofluorescence
microscopy after staining the cells with antibody or isotype
controls. As shown in Fig. 1, the proportion of HSV-infected
DC peaked and plateaued at an MOI of 4 after infection with
all HSV strains, at which 	80% of the viable DC population
displayed HSV antigens. Increasing the infectious dose to an
MOI of 10 did not result in an increase in the number of HSV
antigen-positive DC beyond this value. Thus, consistent with
previous reports of HSV-1 infection of immature human DC,
a population of murine BMDC remains refractory to either
HSV-2 or HSV-1 infection even at a high MOI. Of note, the
percentage of DC that had taken up either UV-inactivated
strain was approximately the same as for the wt strains (except
for UV-HSV-1 at an MOI of 1).
HSV-2 undergoes de novo viral gene expression in immature
murine BMDC but does not generate free infectious progeny.
To test if wt HSV-2 undergoes de novo gene expression in
murine DC after entry, the expression of either the HSV early
protein, ICP8, or the late protein, gD, was examined in HSV-
infected adult BMDC or mock-infected controls by immuno-
fluorescence microscopy. The results are shown in Fig. 2. ICP8
was detected in	10% of the cells at 2 h p.i. in a predominantly
perinuclear pattern and then in 80% of DC by 4 h p.i. in a fine,
granular pattern spread evenly throughout the cytoplasm. The
intensity of ICP8 staining fell after that time point, reaching
undetectable levels by 18 h p.i. (not shown). At no time was the
characteristic localization of ICP8 (13) to the nucleus ob-
served, although faint nuclear staining could be observed in a
small proportion of HSV-infected cells at 2 h p.i. Staining for
the late protein, gD, was detected by 4 h, with peak signal
intensity and percentage of infected cells seen at 6 h p.i., after
which expression fell, becoming undetectable by 18 h p.i. (not
shown). No ICP8 staining was detected in UV-HSV-2-infected
DC up to 12 h p.i. (not shown) or in mock-infected controls.
Thus, there is de novo expression of HSV-2 gene products in
immature murine DC in the early stages of infection but not at
later time points (i.e., 18 h p.i.), by which time up to 90% of DC
are nonviable.
To test if wt HSV productively infects adult murine DC,
BMDC were cultured with wt HSV-2 or wt HSV-1 or mock
infected, acid washed to remove unbound and surface-bound
FIG. 1. Infection of murine BMDC by HSV according to virus type
and dose. CD11c BMDC were infected at a range of MOI as shown
with either wt HSV-2 or UV-HSV-2 (A) or with wt HSV-1 or UV-
HSV-1 (B). DC were mounted on slides, fixed, and permeabilized at
12 h p.i and then stained with HSV type-specific antibody and coun-
terstained with DAPI. The proportion of DC expressing HSV proteins
was determined by immunofluorescence microscopy using five slides
per strain. Mock-infected cells did not stain for HSV proteins. Shown
are average values 
 standard errors of the mean (error bars are too
small to be visualized) from one of three independent experiments
with similar results.
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virions, cultured for various times in medium supplemented
with GM-CSF, and then analyzed for infectious virus by stan-
dard plaque assay. As shown in Fig. 3, we were unable to detect
a significant increase in the infectious titer of HSV-2 or HSV-1
over the residual surface-bound virus left after acid stripping.
Time points were not recorded beyond 24 h post-HSV-2 in-
fection, as all DC were nonviable by that time. Thus, infection
of murine BMDC with HSV of either serotype was nonpro-
ductive.
HSV-2 causes rapid cytolysis of murine DC. HSV-2 has a
more rapid replication cycle than HSV-1. To compare the
effect of HSV-2 on the viability of BMDC from adult mice, DC
were infected with wt HSV-2, wt HSV-1, or the relevant UV-
inactivated HSV strains (at the same preinactivation MOI) or
left untreated. DC viability was determined by trypan blue
exclusion after incubation for 0 to 24 h. Strikingly, wt HSV of
either serotype induced rapid cell death in infected DC, with
	40% cell death seen by 12 h and almost no viable DC ob-
served 24 h after wt HSV-2 infection at an MOI of 4 (Fig. 4A).
In contrast, the viability of DC infected with the respective
UV-inactivated HSV strains was equivalent to the viability of
uninfected DC cultured for the same period at all times p.i. (P
 0.01; wt HSV-1 or wt HSV-2 versus UV-HSV-1 or -2, re-
spectively, at 12, 18, and 24 h p.i.; Wilcoxon’s rank sum test)
(Fig. 4A). At later time points, the level of cell death induced
by HSV-1 was significantly less than the level of wt HSV-2-
induced cell death (P  0.01; wt HSV-1 versus wt HSV-2 at 18
and 24 h p.i.; Wilcoxon’s rank sum test). Similar results were
obtained when we used a clinical HSV-2 isolate (9836-4) or
laboratory-adapted HSV-1 strains (KOS and HSV-1 mP) (not
shown). Thus, HSV induces cytotoxicity in murine BMDC at a
serotype-dependent rate.
The detrimental effects of wt HSV-2 (Fig. 4B) and wt HSV-1
(not shown) on BMDC viability was observed to be dose de-
pendent. Thus, wt HSV induces rapid cytolysis of murine
BMDC that is dependent upon viral gene expression.
HSV-2 induces a mixed picture of spontaneous apoptosis
and necrosis in murine BMDC. To test if the loss of viability
observed after HSV infection of murine BMDC was due to
apoptosis or to necrosis, DC were infected with the wt and
UV-inactivated strains of either HSV-1 or HSV-2 at an MOI
of 4. The level of caspase-3 activity in HSV-infected DC lysates
compared to untreated controls was determined at the times
listed above. We observed activation of caspase-3 in DC in-
fected with wt HSV-2 by 6 h p.i., and it had increased to almost
FIG. 2. HSV-2 undergoes de novo viral gene expression in infected
murine BMDC. CD11c BMDC were infected with wt HSV-1 or -2 at
an MOI of 4 or left untreated and then incubated for up to 18 h. DC
were collected from separate wells of a 24-h plate for each time point,
mounted on slides (n  5 slides/group/time point), fixed, permeabil-
ized, and then stained with antibody specific for either the HSV early
protein, ICP8 (383), or the late protein, gD (910). Shown are immu-
nofluorescence microscope images of HSV-2-infected DC stained for
ICP8 or gD at 2, 4, 6, or 16 h p.i. (magnification, 100). No signal was
detected in mock-infected cells after staining them for ICP8 or gD
(UI) nor for ICP8 in UV-HSV-2-infected DC to 12 h p.i. (not shown).
The results shown are from one of three independent experiments with
similar results.
FIG. 3. Infection of murine BMDC with HSV-1 or -2 is not pro-
ductive of infectious progeny. CD11c DC were infected with wt
HSV-2 or wt HSV-1, both at an MOI of 4, or left untreated; washed in
acid three times to remove any excess bound virus; and then plated at
a concentration of 4  105 DC/well in 24-well plates in 2 ml of
GM-CSF-supplemented medium/well. At the times shown, the me-
dium was aspirated (n 3 wells of DC/group/time point) and frozen at
80°C until the assay. Medium was not harvested from HSV-2-in-
fected DC beyond 24 h p.i., as they were all nonviable after that time.
The titer of infectious virus in the supernatant was determined by
standard plaque assay. Shown are the mean values 
 standard errors
of the mean. The results shown are from one of two independent
experiments with similar results. The level of detection is indicated by
the arrow.
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three times the level of activity in untreated controls by 12 h
p.i. (Fig. 5) (P  0.05; wt HSV-2-infected DC compared to
uninfected controls at 12 h p.i.; Student’s t test). In contrast, no
increase in the activation of caspase-3 was observed in DC
infected with wt HSV-1 or either UV-inactivated strain as late
as 12 h p.i.
As it is possible that caspase-3 became activated in the
HSV-infected DC but did not result in apoptosis, we sought
further evidence of the presence of apoptosis in murine DC
induced by wt HSV-2 infection. We examined DC by TEM at
2 and 6 h p.i. with wt HSV-2 or wt HSV-1, together with
mock-infected controls. Although most DC remained viable at
these times post-HSV infection, we observed characteristic
ultrastructural evidence of various stages of apoptosis in many
HSV-2-infected DC even at 6 h p.i. (Fig. 6A), ranging from
early changes, in which the nuclear chromatin was condensed
in apposition to an intact nuclear envelope, to condensed chro-
matin with loss of the nuclear envelope, to frank necrosis.
Similar findings were observed after HSV-1 infection of
BMDC, although there were notably fewer apoptotic DC at
that time (not shown). In contrast, uninfected control DC
showed no evidence of necrosis or apoptosis (Fig. 6B). The
observed ultrastructural features of apoptosis post-HSV infec-
tion were similar to apoptosis induced by treatment of BMDC
with UV light (Fig. 6C) and to published reports of ultrastruc-
tural features of apoptotic DC (14). To determine the propor-
tion of apoptotic DC in the HSV-2-infected DC or uninfected
controls, we performed quantitative analysis of adjacent tolu-
idine blue-stained semithin sections of the same DC pellets by
light microscopy. We observed that 	15% of HSV-2-infected
DC were apoptotic by 6 h p.i., equivalent to the percentage
observed to be nonviable by trypan blue exclusion at that time
(not shown). Thus, wt HSV-2 infection of murine BMDC in-
duces a mixed picture of apoptosis and necrosis in murine
BMDC shortly after infection.
To test if the apoptotic DC in the BMDC cultures were
themselves HSV infected or were uninfected bystander DC,
cells were collected at times up to 12 h p.i. and then examined
by double immunofluorescence (TUNEL assay) for DNA
breaks and the HSV protein ICP8 or gD. Consistent with
earlier experiments, we observed that by 2 h p.i., cell viability
was 100% (trypan blue) and that 	40% of the cells stained
positive for HSV ICP8 in the cytoplasm and, on occasion, the
nucleus (Fig. 7A). Approximately 15 to 20% of DC showed
evidence of apoptosis by TUNEL staining at that time (Fig.
7B), all of which were found to be HSV infected (Fig. 7C). No
staining or apoptosis was observed in uninfected BMDC at
that time (Fig. 7D), but TUNEL-positive cells could be de-
tected after treatment with DNase (Fig. 7E). The level of ICP8
staining was too low at 6 and 12 h p.i. to allow accurate
determination of the percentage of HSV-infected, apoptotic
DC. Therefore, we tested by double staining for gD and apo-
ptosis (TUNEL). We observed that although 80% of DC ex-
pressed HSV gD by 12 h p.i. and the total viability of the DC
(by trypan blue exclusion) had fallen to 60%, the proportion of
apoptotic DC remained constant at 20%, and they were once
FIG. 4. wt HSV induces rapid cytolysis of murine BMDC at a serotype-dependent rate. CD11c BMDC were infected with wt HSV-2,
UV-HSV-2, wt HSV-1, or UV-HSV-1, all at an MOI of 4 (preirradiation titer) (A) or with wt HSV-2 at an MOI of 0.4 or 4 (B) or left untreated
(Uninfected) (A and B) and then incubated in medium supplemented with GM-CSF. At the times shown, the percentage of viable DC was
determined by trypan blue exclusion (n  3 to 7 dishes of DC/group/time). Shown are the mean values 
 standard errors of the mean (some error
bars are too small to be visualized). The results shown are from concurrent experiments and are representative of one of three independent
experiments with similar results. *, P  0.01 (wt HSV-1 or -2 versus UV-HSV-1 or -2, respectively, at 12, 18, and 24 h p.i.; Wilcoxon’s rank sum
test; n  7/group); **, P  0.01 (wt HSV-1 versus wt HSV-2 at 18 and 24 h p.i.; Wilcoxon’s rank sum test; n  7/group).
FIG. 5. HSV-2 induces activation of caspase-3 in murine BMDC.
BMDC were infected with wt HSV-2, wt HSV-1, UV-HSV-2, or UV-
HSV-1 (all at an MOI of 4 [preirradiation titer for UV strains]) or left
untreated (Uninfected) and incubated for 2, 6, or 12 h. The level of
caspase-3 activity in the supernatant-free cell pellet of HSV-infected
DC from each strain (106 cells/strain in triplicate) was determined
using a colorimetric assay for caspase-3 in a 96-well plate (optical
density reading at a wavelength of 405 nm using a microplate reader)
and compared with the activities of uninfected DC controls and back-
ground controls (no cell lysate), which were normalized to a value of 1.
Shown are average values 
 standard errors of the mean from one of
three independent experiments with similar results. P  0.01 (Stu-
dent’s t test; wt HSV-2 versus uninfected DC; 12 h p.i.).
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FIG. 6. HSV-2 induces ultrastructural changes of apoptosis in a subpopulation of BMDC by 6 h p.i. BMDC were infected with wt HSV-2 (186)
or wt HSV-1 (MC-1), both at an MOI of 4, or left untreated and incubated for 2 or 6 h in GM-CSF-supplemented medium. The DC were pelleted
(106 cells for each strain) and then fixed, embedded in resin, and cut as ultrathin sections on a microtome; the sections were collected on thin-bar
copper grids, stained (1% uranyl acetate in 50% ethanol and Reynold’s lead citrate), and examined by TEM. Shown are electron micrographs of
BMDC infected with wt-HSV-2 and displaying typical nuclear features of apoptosis (condensation of chromatin) at different stages, ranging from
early apoptosis (arrowhead) to apoptotic necrosis (arrows) (A), uninfected BMDC which are uniformly healthy (B), and early (arrowhead) and
late (arrow) stages of apoptosis in uninfected BMDC induced by treatment with UV light for 2 min and incubation in serum starvation medium
for 3 h (C). Bars  3 m.
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again seen only in the HSV-infected (gD-positive) DC popu-
lation (not shown).
HSV infection of immature murine BMDC induces modest
type-specific effects on the DC immunophenotype by 12 h p.i.
HSV-1 has been shown to alter the cell surface phenotypes of
both immature (19, 27) and mature (15, 19) human MoDC. To
test the effect of HSV on the surface immunophenotype of
murine BMDC, DC were infected with either wt HSV strain or
with the UV-inactivated strains at the same preinactivation
dose or left untreated. FACS analysis for MHC-I and -II mol-
ecules and for the costimulatory markers CD80, CD86, and
CD40 was performed 12 h p.i. Although we had previously
shown that a proportion of HSV-infected DC were nonviable
at 12 h p.i., this time was chosen to reflect the approximate
time that DC signal naive T cells in draining lymph nodes in
vivo after migration from the site of HSV infection (22). Non-
viable cells were excluded by counterstaining them with PI,
and the degrees of HSV infection (	80% of viable DC) for
all groups were confirmed to be equivalent by immunoflu-
orescence microscopy for HSV antigens. The mock-infected
BMDC population was shown to consist of 	80% immature
DC (MHC-IIlo CD86lo) and 20% mature DC (MHC-IIhi
CD86hi) (Fig. 8A). By 12 h p.i., wt HSV-2 upregulated DC
MHC-II expression in the MHC-IIlo population, resulting in
loss of the biphasic pattern of expression observed in mock-
infected controls, but did not significantly alter the level of
surface CD40, CD80, or CD86 compared to that in mock-
infected controls (Fig. 8A). MHC-I expression was downregu-
lated in a subpopulation of DC by wt HSV-2 but not by UV-
HSV-2, suggesting that de novo expression of an HSV gene
product(s) was responsible for this phenomenon. In contrast to
wt HSV-2, wt HSV-1 had little effect on surface MHC-II,
MHC-I, or costimulatory molecule expression in murine DC,
aside from upregulation of surface CD40 (Fig. 8A). This up-
regulation was also seen after infection with UV-inactivated
HSV-1, which in addition upregulated expression of MHC-I,
CD80, and CD86 but had no effect on MHC-II expression.
Thus, HSV infection of murine BMDC has serotype-specific
effects on the DC surface immunophenotype.
HSV is highly virulent in newborn humans and mice. As part
of ongoing studies to explore immunological mechanisms be-
hind the age-related defective response to HSV, we tested the
effect of HSV-2 infection on the surface immunophenotype of
murine BMDC that had been derived from 1-week-old mice
(Fig. 8B). The surface immunophenotype of uninfected neo-
natal BMDC generated after 10 days of culture in GM-CSF-
supplemented medium was more immature than that of the
BMDC from adult mice derived in the same manner in that
there were lower levels of MHC-II and CD86 expression in
both the MHC-IIlo and MHC-IIhi populations. Infection with
wt HSV-2 had more profound effects on neonatal DC than it
did on DC from adult counterparts. Wt HSV-2, but not UV-
HSV-2, resulted in downregulation of surface MHC-I, MHC-
II, and CD86 but had differential effects on the surface expres-
FIG. 7. Subpopulation of HSV-2-infected BMDC exhibit DNA breaks shortly after infection. BMDC were infected with wt HSV-2 at an MOI
of 4 or left untreated, incubated for up to 12 h p.i., and then double stained for HSV ICP8 (anti-ICP8 MAb 383 plus FITC-conjugated goat
anti-mouse MAb) and for apoptosis (biotin-labeled dCTP followed by avidin-Texas Red). Shown are immunofluorescence microscope images of
the same optical section of a population of HSV-2-infected DC collected 2 h p.i. to demonstrate staining for ICP8 (green) (A), nick end-labeled
DNA breaks (TUNEL) (red) (B), and a double-labeled, HSV-2-infected, apoptotic BMDC (yellow). Arrow in panels A, B, and C indicates positive
staining of an apoptotic, HSV-2-infected BMDC. Included were double-stained uninfected BMDC as a negative control (D) and DNase-treated
uninfected DC stained with biotin-dCTP-avidin-Texas red as a positive control (E) for the TUNEL assay. Magnification, 40.
FIG. 8. Effects of HSV on the immunophenotype of murine
BMDC according to virus strain and age. CD11c BMDC derived
from adult female mice (A) or from 1-week-old mice (B) were infected
at an MOI of 4 with wt HSV-2 or UV-HSV-2 (A and B) or with wt
HSV-1 or UV-HSV-1 (adult mice alone) (A) or left untreated (Mock)
(A and B); incubated for 12 h; stained for surface MHC-I, MHC-II,
CD40, CD80, and CD86 expression (solid curves) or with isotype
controls (open curves); and then analyzed by FACS. Dead cells were
excluded by costaining them with PI. The results shown are from one
of three independent experiments.
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sion of CD40, with two populations becoming evident: CD40hi
and CD40lo (Fig. 8B). Neonatal murine BMDC failed to up-
regulate MHC-II in response to wt HSV-2, as observed in adult
mice. Thus, there are some age-related differences in the ef-
fects of HSV-2 infection on the surface immunophenotype of
murine BMDC in vitro.
HSV-2 infection impairs murine BMDC alloproliferative
response. DC are potent stimulators of naive T cells. The
ability of DC to induce an allogeneic T-cell proliferative re-
sponse is therefore an important measure of their function. To
test the effect of HSV-2 infection on the ability of DC to induce
an alloproliferative T-cell response, BMDC from BALB/c mice
(H-2b) were infected with either wt HSV or the UV-inactivated
strains at an MOI of 4 or left untreated and then irradiated.
After 12 h of incubation (to mimic the time p.i. of T-cell
signaling in vivo) (22), serial dilutions of viable DC from each
group were incubated with splenocytes from naive adult
C57BL/6 mice (H-2d), cultured for 3 days, and labeled with
[3H]thymidine, and the degree of DC-induced alloproliferation
was determined by standard techniques. As expected, increas-
ing numbers of uninfected DC resulted in a proportionate
increase in the alloproliferative response (Fig. 9). Infection of
DC with UV-inactivated HSV had no effect on the allostimu-
latory capacity of the DC. In marked contrast, infection of DC
with either wt HSV strain reduced the T-cell proliferative
response to background levels at all DC dilutions, reaching
statistical significance for DC/T-cell ratios of 1:50 and above
(Fig. 9) (P  0.01; Wilcoxon’s rank sum test; wt HSV-1 or -2
versus uninfected DC or versus UV-HSV-1- or UV-HSV-2-
infected DC, respectively). The same phenomenon was ob-
served when DC were incubated with mismatched splenocytes
immediately after wt HSV-2 infection (not shown). Thus, wt
HSV infection of murine BMDC inhibits the allostimulatory
capacity of DC.
HSV-2 infection impairs DC LPS-induced secretion of IL-
12. The induction of a Th-1 cytokine producing T-cell effectors
has been shown to be essential for protection against intracel-
lular pathogens like HSV. DC have recently been identified as
the principal Th1-inducing cytokine in the primary T-cell re-
sponse. Therefore, we compared the ability of wt HSV-in-
fected DC to produce IL-12 with or without additional stimu-
lation with LPS or CD40 ligation to the level produced by
uninfected DC or DC infected with UV-inactivated HSV
strains under the same conditions. CD40 ligation with MAb
failed to produce detectable levels of IL-12, even by uninfected
murine BMDC at 12, 24, 48, and 72 h p.i. (not shown). Shown
in Fig. 10 are the levels of IL-12 in the supernatant after
BMDC were infected and then incubated for 24 h, the time of
optimal IL-12 production by uninfected, LPS-stimulated DC in
our system (not shown). IL-12 production in the absence of
stimuli in uninfected DC or after infection with wt HSV-1 or -2
was at the level of detection of the assay. Infection with either
UV-inactivated HSV strain induced low levels of IL-12, which
increased modestly when costimulated with LPS. Strikingly,
infection of DC with either wt HSV strain suppressed LPS-
induced DC IL-12 production to background levels (P  0.01;
Student’s t test; wt HSV-1- or wt HSV-2-infected DC plus LPS
versus uninfected DC plus LPS). IL-12 production by wt HSV-
2-infected DC at earlier time points (12 and 18 h p.i.) showed
similar suppression (not shown). Thus, wt HSV infection of
BMDC reduced their ability to produce IL-12 in response to
stimulation.
DISCUSSION
Here, we describe the novel finding that HSV induces rapid
cell death in murine BMDC at a serotype-dependent rate, with
FIG. 9. HSV-2 infection of murine BMDC impairs DC-induced
T-cell alloproliferation. CD11c DC derived from BALB/c mice (H-
2d) were infected with wt HSV-2, wt HSV-1, or the respective UV-
inactivated strains (UV-HSV-2 or UV-HSV-1), all at an MOI of 4, or
left untreated (Uninfected) and then incubated for 12 h. Viable DC
were irradiated and then incubated with T cells derived from the
spleens of C57BL/6 mice (H-2b) at ratios of 0.01:1 to 1:1 (105 T
cells/well; n  6 wells per DC/T cell ratio per strain) for 3 days. The
cultures were then labeled with [3H]thymidine, and the levels of 3H
incorporation were determined after 18 h. Shown are the mean values

 standard errors of the mean. The results shown are from one of two
independent experiments with similar results. Proliferation of T cells in
the absence of DC was negligible. *, P  0.01 (Wilcoxon’s rank sum
test; wt HSV-2 or wt HSV-1 versus uninfected DC or versus the
respective UV-inactivated strain; n  6 observations/group).
FIG. 10. HSV impairs LPS-induced IL-12 secretion by murine
BMDC. CD11c BMDC were infected with wt HSV-1 or -2 or the
respective UV-inactivated HSV-2, all at an MOI of 4, or left untreated
(Uninfected); washed; and then plated in 96-well plates and coincu-
bated with LPS (50 ng/ml) for 24 h or in GM-CSF-supplemented
medium alone (Unstimulated) (106 DC/well in triplicate per strain per
treatment), and the level of IL-12 in the supernatant was determined
by capture enzyme-linked immunosorbent assay. The level of sensitiv-
ity of the assay was 31.3 pg/ml. Shown are mean values 
 standard
errors of the means. The results shown are from one of five indepen-
dent experiments with similar results. P  0.01 (Student’s t test; wt
HSV-2- or wt HSV-1-infected and LPS-treated DC compared to un-
infected and LPS-treated DC).
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HSV-2 being more potent than HSV-1 in this regard. The type
of HSV-induced cell death was shown to be a mixed picture of
necrosis and apoptosis. The phenomenon was not simply due
to consumption of nutrients in the media, as uninfected DC
remained viable throughout the period of observation. De
novo HSV gene expression was required to induce BMDC cell
death, as shown by the failure of UV-inactivated HSV strains
(type 1 or 2) to reproduce this effect. Apoptosis was observed
only in HSV-infected cells, but not all HSV-infected cells were
apoptotic. It was also seen predominantly at early times, raising
the possibility that many of the cells observed to be in the
advanced stages of necrosis by 6 and 12 h p.i. by TEM and
trypan blue may have progressed to this stage via apoptosis.
Alternatively, there were two concurrent types of cell death
occurring.
In contrast to our observations in BMDC, HSV has been
shown to strongly inhibit apoptosis induced by the virus itself in
a number of cell types, including HEp-2 cells (7), Jurkat cells
(11), PC-12 cells (21), and murine neurons (2, 24). The virus
can also protect infected cells against apoptosis induced by
external triggers, including Fas, C2-ceramide, and both os-
motic and thermal shock, although the degree of protection
varies with the cell type studied (8). Consistent with our ob-
servations in murine DC, spontaneous induction of apoptosis
by HSV has been reported in activated human cord blood T
cells (10), in activated murine and human T cells (25), and in
freshly isolated murine macrophages after infection in vitro
with HSV (5). Thus, cells of hematological origin may reflect
one end of the spectrum in which the balance between virus-
induced apoptosis and virus-induced inhibition of apoptosis at
times favors the former. This is not specific to DC of murine
origin, as shown by similar observations made in human
MoDC (L. Bosnjak, M. Miranda-Saksena, C. A. Jones, R. A.
Boadle, Z. Mikloska, and A. L. Cunningham, unpublished
data), although the effect was much more rapid in mice.
Intertypic differences in the ability of HSV to protect against
apoptosis have been reported. HSV-1 has been shown to be a
more potent inhibitor of apoptosis induced by UV light or by
anti-Fas antibody than HSV-2 (11). Although this effect was
seen for both low-passage clinical isolates and laboratory-
adapted HSV-1 strains, only laboratory-adapted HSV-2 strains
protected cells against externally triggered apoptosis. Impor-
tantly, neither laboratory-adapted strains nor clinical HSV-2
isolates were by themselves shown to induce apoptosis in other
cell types up to 48 h p.i. (16). Consistent with these earlier
reports, we found that HSV-2 was a more potent trigger for
apoptosis than HSV-1. However, we observed no difference
between the abilities of clinical and laboratory-adapted isolates
of HSV-2 (or HSV-1) to induce apoptosis at 12 h p.i. in murine
BMDC.
Infection with increasing doses of wt HSV or UV-inactivated
virus of either HSV type resulted in an increased percentage of
infected DC until a plateau was reached, similar to an earlier
observation with HSV-1 infection of human MoDC (19).
Whereas the previously reported human MoDC were a largely
immature population, our DC population contained 	10 to
15% mature DC (CD11c MHCIIhi), which may be synony-
mous with the group that was refractory to infection in our
population. All DC in our study rapidly died after exposure to
HSV of either type, suggesting that the uninfected subpopula-
tion did not die directly from viral infection but from a by-
stander mechanism. A further study is under way to explore
this possibility.
HSV underwent de novo expression of early and late pro-
teins in murine BMDC after both HSV-2 and HSV-1 infection.
However, for reasons that remain to be elucidated, the kinetics
of HSV-2 expression in murine DC was more rapid than pre-
viously observed in cells of primate origin (34). Infection of the
murine BMDC with either strain appeared to be abortive, as
we did not detect any significant increase in the titer of infec-
tious virus released into the supernatant during prolonged
culture. A likely explanation is that the rapid induction of cell
death by both HSV-2 and HSV-1 in the murine BMDC inhibits
completion of the viral replication cycle and release of infec-
tious progeny. This is supported by the findings that the single-
stranded DNA binding protein, ICP8, remained predomi-
nantly cytoplasmic and did not exhibit the characteristic
localization to the nucleus (13) and that early and late protein
expression was markedly reduced at 16 h p.i. instead of being
strong. Using the same clinical HSV-1 isolate (19), HSV-1 has
been shown to productively infect immature MoDC of human
origin, although the levels of infectious virus produced were
very low. The different observations could be explained by the
different rate of induction of apoptosis between the two spe-
cies. The permissiveness of human DC for HSV replication
also appears to differ with the maturation state of the DC, with
nonproductivity reported after incubation of mature MoDC
with the laboratory-adapted HSV-1 strain, Ang (14).
Intertypic differences were also observed in both the extent
to which HSV affects the DC immunophenotype and the ki-
netics of this effect. Although a proportion of DC were apo-
ptotic at the time point studied, only viable cells were included
in the analysis, of which 80% were HSV infected. We observed
that wt HSV-2 induced moderate downregulation of MHC
class I expression, in contrast to no detectable change after
infection with UV-HSV-2. This suggests that the mechanism
by which wt HSV-2 exerted this effect was not due to viral
entry. MHC class I expression has been shown to be reduced in
a variety of human cell types by HSV ICP47 (type 1 and type
2) inhibition of TAP. However, as HSV ICP47 has been shown
to be only a weak inhibitor of murine TAP (6, 9, 32), it is
possible that an alternative mechanism exists in the mouse to
impair MHC class I presentation. The effect of the clinical
HSV-1 isolate on the adult murine DC immunophenotype by
12 h p.i. was minimal, consistent with previous observations
using the same strain in human MoDC at the same time point
(19).
We observed an age-related difference in the effects of
HSV-2 on the DC immunophenotype, with greater wt HSV-
2-induced downregulation of MHC class I and CD86 in neo-
natal BMDC than was observed in infected adult counterparts.
Both the CD28/CD80-86 and the CD40/CD40 ligand (CD154)
costimulatory pathways have been shown to be important for
the induction of the primary T-cell response to HSV in mice,
using reagents that block the pathway, and mice with genetic
defects in the relevant receptors (3). Neonatal T cells have
been shown to require increased costimulatory signals to
achieve the adult levels of activation to a predetermined stim-
ulus. Supporting this notion, neither wt HSV-2 or UV-HSV-2
induced the same degree of maturation in newborn DC that
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was observed with adult DC, suggesting that BMDC derived
from neonatal mice do not mature to the same extent as their
adult counterparts in response to the same signal. Thus, it is
possible that HSV-induced reduction in surface DC costimu-
latory molecule expression may further reduce the ability of
naive neonatal T cells to become activated in the mucosa or in
the draining lymph nodes.
Infection of the BMDC with wt HSV of either serotype
significantly reduced their ability to stimulate an alloprolifera-
tive response or to secrete IL-12, in contrast to DC that had
been infected with a UV-inactivated strain. T-cell activation
occurs rapidly after T-cell receptor engagement with the DC;
therefore, although wt HSV-2 had induced cell death in most
of the BMDC by the time the alloproliferation assay was com-
pleted, these functional impairments were likely due to “apo-
ptosis in progress,” resulting in disarranged cell architecture.
However, reproduction of the results of the alloproliferation
assays with HSV-2 DC set up 1 h p.i. also suggests the possi-
bility of an additional virus-induced block to function (C. A.
Jones, M. Fernandez, and K. Herc, unpublished observations).
IL-12 is thought to be the principal Th-1-driving cytokine dur-
ing a primary immune response to a pathogen (18). As HSV
induces a predominantly CD4 Th1 response early in infection,
this suggests that bystander DC primed with HSV antigen play
a greater role in the induction of the HSV-specific CD4 T-cell
response than HSV-infected DC. Our findings are in contrast
to the observations that wt HSV-1 (KOS) infection of murine
“splenocyte-enriched DC” at a comparable MOI upregulates
IL-12 p40 mRNA expression by 12 h p.i (12). In the same
study, UV-inactivated HSV-1 induced only minor IL-12
mRNA upregulation at the same time points. Low-level induc-
tion of IL-12 p40 mRNA expression was also demonstrated in
the draining lymph nodes after footpad inoculation with wt
HSV-1. It is possible that the observed differences in HSV-
induced production of IL-12 by DC are due to differences in
the types of cells being studied (i.e., a highly purified popula-
tion of BMDC compared to splenocyte-enriched DC that were
derived by passing splenocytes through a metrizamide gradi-
ent, which, as acknowledged by the authors, also contained
many macrophages and neutrophils, without further purifica-
tion). Alternatively, it may relate to the types of assays used to
measure IL-12 production. Reverse transcription-PCR deter-
mination of IL-12 p40 mRNA expression (12) would fail to
detect a posttranscriptional HSV-induced block to IL-12 se-
cretion, which could be detected by determination of the level
of IL-12 heterodimer in infected DC supernatant, as used in
our experiments. Further studies to test the effect HSV infec-
tion on IL-12 secretion and expression in DC derived directly
ex vivo, or draining lymph node cells after infection in vivo, are
under way.
These experiments indicate that HSV-2 has differential ef-
fects on DC immunobiology in mice in vitro compared to
HSV-1. Whether this translates into important functional ef-
fects in the natural history of HSV infection in vivo in mice or
humans has yet to be determined. HSV-2 replication-defective
vectors expressing simian immunodeficiency virus genes have
been shown to be less potent inducers of cytolytic T-cell re-
sponses in monkeys than HSV-1 expressing the same gene
product (D. Knipe, personal communication). Exploration of
the intertypic differences in the effects of HSV on DC structure
and function may provide valuable insights into the molecular
mechanisms behind the induction of a protective anti-HSV
immune response.
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